Nicole Kucine

870 total citations
25 papers, 386 citations indexed

About

Nicole Kucine is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Nicole Kucine has authored 25 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 14 papers in Genetics and 8 papers in Rheumatology. Recurrent topics in Nicole Kucine's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Eosinophilic Disorders and Syndromes (7 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). Nicole Kucine is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Eosinophilic Disorders and Syndromes (7 papers) and Venous Thromboembolism Diagnosis and Management (7 papers). Nicole Kucine collaborates with scholars based in United States, Italy and Canada. Nicole Kucine's co-authors include Ross L. Levine, Omar Abdel‐Wahab, Carles Besses, Verónica Rodilla, Anna Bigas, Josep Nomdedéu, Beatríz Bellosillo, Jordi Guiu, Teresa D’Altri and Lluı́s Espinosa and has published in prestigious journals such as Blood, Cancer Cell and Aging Cell.

In The Last Decade

Nicole Kucine

18 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicole Kucine United States 6 203 142 140 80 58 25 386
Jo-Anne Vergilio United States 7 147 0.7× 166 1.2× 198 1.4× 97 1.2× 47 0.8× 8 457
Monika J. Stankiewicz United States 7 171 0.8× 90 0.6× 171 1.2× 30 0.4× 63 1.1× 11 336
Kaitlyn Shank United States 10 382 1.9× 211 1.5× 296 2.1× 63 0.8× 36 0.6× 19 555
Alice Marceau‐Renaut France 11 200 1.0× 143 1.0× 400 2.9× 90 1.1× 58 1.0× 42 505
Fernanda Gutierrez‐Rodrigues United States 13 194 1.0× 197 1.4× 281 2.0× 49 0.6× 98 1.7× 44 708
Anne Stidsholt Roug Denmark 13 213 1.0× 133 0.9× 286 2.0× 100 1.3× 118 2.0× 53 522
Ulrich Pascheberg Germany 10 140 0.7× 79 0.6× 211 1.5× 37 0.5× 33 0.6× 12 327
Mary Alikian United Kingdom 11 74 0.4× 177 1.2× 204 1.5× 29 0.4× 22 0.4× 18 346
Salvatore Nicola Bertuccio Italy 10 183 0.9× 49 0.3× 152 1.1× 57 0.7× 27 0.5× 28 365
Mridul Agrawal United States 8 64 0.3× 128 0.9× 187 1.3× 56 0.7× 46 0.8× 12 289

Countries citing papers authored by Nicole Kucine

Since Specialization
Citations

This map shows the geographic impact of Nicole Kucine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Kucine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Kucine more than expected).

Fields of papers citing papers by Nicole Kucine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Kucine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Kucine. The network helps show where Nicole Kucine may publish in the future.

Co-authorship network of co-authors of Nicole Kucine

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Kucine. A scholar is included among the top collaborators of Nicole Kucine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Kucine. Nicole Kucine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kucine, Nicole, Holger Cario, Ghaith Abu‐Zeinah, et al.. (2025). A Toolkit for Healthcare Transition for Adolescents With Classical Myeloproliferative Neoplasms. Pediatric Blood & Cancer. 72(5). e31633–e31633.
2.
Savenkov, Oleksandr, et al.. (2024). Cytoreductive therapy in younger adults with polycythemia vera: a meta-analysis of safety and outcomes. Blood Advances. 8(10). 2520–2526. 4 indexed citations
3.
Betensky, Marisol, Cristina Tarango, Anupam Verma, et al.. (2024). Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial. Blood Advances. 8(22). 5790–5795.
4.
Woods, Gary, Alexandra Miller, Christoph Male, et al.. (2024). Clinical characteristics, treatment, and outcomes of provoked acute cerebral sinovenous thrombosis in patients <21 years old: findings from the Kids-DOTT Multinational Trial. Research and Practice in Thrombosis and Haemostasis. 8(7). 102605–102605. 1 indexed citations
5.
Zhang, Joshua, Julián A. Martínez-Agosto, Christopher Cunniff, et al.. (2023). Bloom syndrome patients and mice display accelerated epigenetic aging. Aging Cell. 22(10). e13964–e13964. 5 indexed citations
6.
Stieglitz, Elliot, et al.. (2023). Too many white cells—TAM, JMML, or something else?. Hematology. 2023(1). 37–42.
7.
Kucine, Nicole, et al.. (2023). Venous Thromboembolism in Pediatric Inflammatory Bowel Disease: A Scoping Review. Journal of Pediatric Gastroenterology and Nutrition. 77(4). 491–498. 3 indexed citations
8.
Kucine, Nicole. (2023). PB0290 Bleeding Complications in Children with Myeloproliferative Neoplasms and Thrombosis on Anticoagulation. Research and Practice in Thrombosis and Haemostasis. 7. 101422–101422.
10.
Leguit, Roos J., Attilio Orazi, Nicole Kucine, et al.. (2022). EAHP 2020 workshop proceedings, pediatric myeloid neoplasms. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(4). 621–646. 5 indexed citations
11.
Cooley, Victoria, et al.. (2021). Assessment of provider practices regarding venous thromboembolism management and prevention in pediatric acute leukemia patients. Journal of Thrombosis and Thrombolysis. 52(1). 209–213. 2 indexed citations
12.
Cooley, Victoria, et al.. (2021). Health and Financial Burdens Associated With Venous Thrombosis in Hospitalized Children With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 72(5). 748–751. 5 indexed citations
13.
Kucine, Nicole. (2020). Myeloproliferative Neoplasms in Children, Adolescents, and Young Adults. Current Hematologic Malignancy Reports. 15(2). 141–148. 22 indexed citations
14.
Kucine, Nicole, et al.. (2019). Provider Practices Regarding Prophylactic Anticoagulation in Children with Leukemia. Blood. 134(Supplement_1). 3412–3412. 1 indexed citations
15.
Mughal, Tariq I., Naveen Pemmaraju, Jerald P. Radich, et al.. (2019). Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasms. Hematological Oncology. 37(3). 240–252. 4 indexed citations
16.
DeSimone, Robert A., John V. Mitsios, Nicole Kucine, et al.. (2015). Hemoglobin C after a red blood cell transfusion for sickle cell disease. Transfusion. 55(10). 2304–2304.
17.
Kucine, Nicole, Katherine Chastain, Michelle Mahler, & James B. Bussel. (2014). Primary thrombocytosis in children. Haematologica. 99(4). 620–628. 37 indexed citations
18.
Kucine, Nicole & Ross L. Levine. (2011). JAK inhibitors and other novel agents in myeloproliferative neoplasms: are we hitting the target?. Therapeutic Advances in Hematology. 2(4). 203–211. 2 indexed citations
19.
Espinosa, Lluı́s, Séverine Cathelin, Teresa D’Altri, et al.. (2010). The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia. Cancer Cell. 18(3). 268–281. 214 indexed citations
20.
Koppikar, Priya, Omar Abdel‐Wahab, Cyrus V. Hedvat, et al.. (2010). Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis. Blood. 115(14). 2919–2927. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026